Seeking Alpha

Hologic (HOLX +1.7%) shares surge after the FDA approves the company's mammography device that...

Hologic (HOLX +1.7%) shares surge after the FDA approves the company's mammography device that generates 3-D images of the breast, potentially helping doctors' spot cancerous tumors. It is an upgrade to Hologic's existing FDA-approved 2-D system. (PR)
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs